Addex ADX71441 Preclinical Results for Treatment of Alcohol Use Disorder Published in Journal of Psychopharmacology

Geneva, Switzerland, 4 May 2017 – Addex Therapeutics (ADXN.SW) announced today that the results of a preclinical study evaluating ADX71441 in animal models of alcohol use disorder were published in the Journal of Psychopharmacology.  The study was led by Prof. Markus Heilig of Linköping University, Sweden, and was conducted in collaboration with the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a division of National Institutes of Health.